LECIA SEQUIST, MD of Massachusetts General Hospital discusses LUX-Lung 8 trial and the role of EGFR inhibitors in Squamous Cell Carcinoma.
LECIA SEQUIST, MD of Massachusetts General Hospital discusses LUX-Lung 8 trial and the role of EGFR inhibitors in Squamous Cell Carcinoma.